Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants
Phase 2, Randomized, Double-blind, Active-controlled Study Evaluating the Safety and Immunogenicity of IVT PCV-25 in Healthy Infants Administered With the WHO Expanded Programme on Immunization 3+0 Vaccine Schedule
Sponsor: Grand Centennial Homes Clinic
This PHASE2 trial investigates Pneumococcal Disease, Invasive and is currently ongoing. Grand Centennial Homes Clinic leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting PHASE2
-
May 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2025 — May 2025 [monthly]
Recruiting PHASE2
First recorded
Jan 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Grand Centennial Homes Clinic
- Health Index Multispecialty Clinic
- Inventprise Inc.
- University of the Philippines-National Health Institute_Doña Nena Health Center
For direct contact, visit the study record on ClinicalTrials.gov .